News

Find News

Filter articles

Applied Filters

Showing 51 to 60 of 706 results

CJEU opinion on SPC referral is ‘overdue’, say lawyers

EU, UK05-03-2019

An opinion on whether a supplementary protection certificate can be granted to an owner of a drug patent when the marketing authorisation is held by a third party is overdue, lawyers told WIPR.

USITC to investigate Daewoong following Allergan complaint

US04-03-2019

The US International Trade Commission has begun an investigation into Daewoong Pharmaceuticals of South Korea and California-based Evolus, following a complaint from Allergan.

Judge orders Boehringer to disclose Humira biosimilar plans

US28-02-2019

A US judge has ordered Boehringer Ingelheim to release its rollout plans for a biosimilar version of Humira (adalimumab), following a request from AbbVie.

Merck to buy immunotherapy company for $300m

US26-02-2019

US-based Merck & Co has announced plans to acquire immunotherapy company Immune Design for $300 million, in a bid to strengthen its capabilities in vaccine development.

Roche to make $4.3bn gene therapy acquisition

US25-02-2019

Switzerland-based Roche will buy gene therapy company Spark Therapeutics in a $4.3 billion deal.

DLA Piper hires two patent litigators in New York

US25-02-2019

DLA Piper has hired two patent litigators as partners in the firm’s IP and technology practice.

Clarivate announces new Life Science Alliances programme

US12-02-2019

Global information company Clarivate Analytics has launched a “Life Science Alliances Program” to provide drug and medical device developers a new way to advance their research and development.

University of California to be granted CRISPR patent

US11-02-2019

The University of California will soon be granted a patent related to the gene-editing technology CRISPR, according to a notice of allowance by the US Patent and Trademark Office.

Victory for Mayo in neurological disorder patent dispute

US07-02-2019

In a victory for Mayo Collaborative Services, a US Court has ruled that four claims in a patent, of which Athena Diagnostics is the exclusive licensee, are invalid.

Celgene signs $1bn deal to develop blood cancer therapy

Canada, US31-01-2019

Global biopharmaceutical company Celgene has signed a collaboration deal worth up to nearly $1 billion to develop a preclinical therapeutic for the treatment of blood cancers, including leukaemia.

Showing 51 to 60 of 706 results

LSIPR